Fennec Pharmaceuticals Inc (FENC)

Nov 13, 2024

DG Capital Management, LLC Adjusts Stake in Fennec Pharmaceutica - GuruFocus.com

Nov 13, 2024

Nov 13, 2024

Fennec Pharmaceuticals to Participate in Upcoming Investor Conference - The Manila Times

Nov 13, 2024

Nov 12, 2024

Fennec Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2024 - Marketscreener.com

Nov 12, 2024

Nov 12, 2024

Fennec Pharmaceuticals Drops To US$4.26, Yet Insiders May Have Sold Too Early - Simply Wall St

Nov 12, 2024

Nov 12, 2024

Fennec Pharmaceuticals Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance

Nov 12, 2024

Nov 11, 2024

Fennec Pharma stock hits 52-week low at $4.07 amid challenges - Investing.com India

Nov 11, 2024

Nov 11, 2024

Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 11, 2024

Nov 11, 2024

Wedbush Analysts Decrease Earnings Estimates for FENC - MarketBeat

Nov 11, 2024

Nov 11, 2024

What is Wedbush's Forecast for TSE:FRX FY2025 Earnings? - MarketBeat

Nov 11, 2024

Nov 10, 2024

Earnings call: Fennec Pharmaceuticals reports robust Q3 growth By Investing.com - Investing.com Australia

Nov 10, 2024

Nov 10, 2024

Earnings call: Fennec Pharmaceuticals reports robust Q3 growth - Investing.com

Nov 10, 2024

Nov 09, 2024

Wedbush Reaffirms “Outperform” Rating for Fennec Pharmaceuticals (NASDAQ:FENC) - Defense World

Nov 09, 2024

Nov 08, 2024

Fennec Pharmaceuticals Inc (FENC) Quarterly 10-Q Report - Quartzy

Nov 08, 2024

Nov 07, 2024

Fennec Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update - The Manila Times

Nov 07, 2024

Nov 07, 2024

Fennec Pharma Q3 Sales Rise to $7M, Losses Widen Despite PEDMARK Reimbursement Success | FENC Stock News - StockTitan

Nov 07, 2024

Nov 06, 2024

Apogee Therapeutics (NASDAQ:APGE) and Fennec Pharmaceuticals (NASDAQ:FENC) Financial Contrast - Defense World

Nov 06, 2024

Nov 05, 2024

FENCFennec Pharmaceuticals Inc. Latest Stock News & Market Updates - StockTitan

Nov 05, 2024

Nov 04, 2024

Insider Sale: Director Rosty Raykov Sells Shares of Fennec Pharm - GuruFocus.com

Nov 04, 2024

Nov 04, 2024

Insider Selling: Fennec Pharmaceuticals Inc (NASDAQ:FENC) Director Sells 2,431 Shares of Stock - MarketBeat

Nov 04, 2024

Nov 04, 2024

Fennec Pharmaceuticals director Raykov Rosty sells $10,477 in stock - Investing.com India

Nov 04, 2024

Nov 04, 2024

Fennec Pharmaceuticals director Raykov Rosty sells $10,477 in stock By Investing.com - Investing.com South Africa

Nov 04, 2024

Nov 01, 2024

Fennec Pharmaceuticals (FENC) to Release Earnings on Thursday - MarketBeat

Nov 01, 2024

Nov 01, 2024

Fennec Pharmaceuticals (FRX) Set to Announce Quarterly Earnings on Thursday - MarketBeat

Nov 01, 2024

Oct 31, 2024

Fennec Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024 - ForexTV.com

Oct 31, 2024

Oct 30, 2024

RTP drugmaker appoints new execs following CEO swap - The Business Journals

Oct 30, 2024

Oct 30, 2024

Fennec Pharmaceuticals Strengthens Leadership Team for Growth - TipRanks

Oct 30, 2024

Oct 29, 2024

Individual investors account for 31% of Fennec Pharmaceuticals Inc.'s (NASDAQ:FENC) ownership, while hedge funds account for 30% - Yahoo Finance

Oct 29, 2024

Oct 29, 2024

Fennec Pharmaceuticals (TSE:FRX) Stock Price Passes Below 50 Day Moving AverageWhat's Next? - MarketBeat

Oct 29, 2024

Oct 28, 2024

Eupraxia Pharmaceuticals Inc. - Baystreet.ca

Oct 28, 2024

Oct 28, 2024

Fennec Pharmaceuticals expands leadership team - The Pharma Letter

Oct 28, 2024

Oct 28, 2024

Fennec Pharmaceuticals Inc. - Baystreet.ca

Oct 28, 2024

Oct 28, 2024

Fennec Pharmaceuticals Strengthens Executive Leadership Team with Three Key Appointments to Accelerate the Company's Next Stage of Growth - The Manila Times

Oct 28, 2024

Oct 28, 2024

Fennec Pharmaceuticals Strengthens Executive Leadership Team with Three Key Appointments to Accelerate the Company’s Next Stage of Growth - ForexTV.com

Oct 28, 2024

Oct 21, 2024

Q3 EPS Estimates for FENC Boosted by Capital One Financial - Defense World

Oct 21, 2024

Oct 21, 2024

Capital One Financial Estimates TSE:FRX Q3 Earnings - MarketBeat

Oct 21, 2024

Oct 19, 2024

Financial Comparison: Kodiak Sciences (NASDAQ:KOD) & Fennec Pharmaceuticals (NASDAQ:FENC) - Defense World

Oct 19, 2024

Oct 11, 2024

Fennec Pharma stock hits 52-week low at $4.11 amid market challenges - Investing.com India

Oct 11, 2024

Oct 11, 2024

Fennec Pharmaceuticals director sells shares worth over $6,000 By Investing.com - Investing.com South Africa

Oct 11, 2024

Oct 10, 2024

Fennec Pharma stock hits 52-week low at $4.11 amid market challenges By Investing.com - Investing.com South Africa

Oct 10, 2024

Oct 10, 2024

Fennec Pharmaceuticals director sells shares worth over $6,000 - Investing.com

Oct 10, 2024

Oct 08, 2024

Fennec Pharmaceuticals (TSE:FRX) Reaches New 12-Month LowTime to Sell? - MarketBeat

Oct 08, 2024

Oct 07, 2024

Fennec: Operational Challenges Persist Despite Improved Financial Position (NASDAQ:FENC) - Seeking Alpha

Oct 07, 2024

Oct 04, 2024

Rostislav Christov Raykov Sells 2,431 Shares of Fennec Pharmaceuticals Inc. (TSE:FRX) Stock - Defense World

Oct 04, 2024

Oct 04, 2024

Revenues Working Against Fennec Pharmaceuticals Inc.'s (NASDAQ:FENC) Share Price - Simply Wall St

Oct 04, 2024

Oct 03, 2024

Fennec Pharma stock hits 52-week low at $4.57 amid market challenges - Investing.com

Oct 03, 2024

Oct 02, 2024

Fennec Pharmaceuticals director sells over $12k in company stock - Investing.com India

Oct 02, 2024

Oct 02, 2024

Norgine Announces Appointment of New CEO Janneke van der Kamp - PR Newswire UK

Oct 02, 2024

Oct 01, 2024

Fennec Pharmaceuticals Inc (NASDAQ:FENC) Director Sells $12,009.14 in Stock - Defense World

Oct 01, 2024

Oct 01, 2024

The past three years for Fennec Pharmaceuticals (NASDAQ:FENC) investors has not been profitable - Yahoo Finance

Oct 01, 2024